Parabilis Medicines

calendar

Biotech

Parabilis’ upsized $670M IPO breaks new record for biotechs

Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for the largest listing in the biotech sector’s history.

James Waldron Jun 10, 2026 4:36am

rollercoaster ride theme park scary crazy

Parabilis ups planned IPO haul to record-setting $637M

Jun 9, 2026 10:22am

IPO initial public offering Wall Street

Parabilis preps $413M IPO to fuel desmoid tumor drug into ph. 3

Jun 4, 2026 10:02am

IPO initial public offering

Parabilis, fresh from inking Regeneron pact, plans IPO

May 20, 2026 5:25am

Regeneron booth at AACR 2026

Regeneron pens $2.3B Parabilis pact to develop new twist on ADCs

May 18, 2026 9:08am

Parachute over La Jolla California

Metsera sale architect swings to Structure—Chutes & Ladders

Apr 17, 2026 10:10am